Geode Capital Management’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Geode Capital Management’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,150	Closed	-$10.7K	–	4649
2023 Q4	$10.7K	Hold	1,150	–	–	﹤0.01%	4581
2023 Q3	$18.2K	Sell	1,150 -41	-3%	-$2.08K	﹤0.01%	4638
2023 Q2	$89.1K	Hold	1,191	–	–	﹤0.01%	4371
2023 Q1	$99.9K	Hold	1,191	–	–	﹤0.01%	4334
2022 Q4	$164K	Sell	1,191 -4	-0.3%	-$496	﹤0.01%	4202
2022 Q3	$124K	Buy	1,195 +9	+0.8%	+$1.77K	﹤0.01%	4467
2022 Q2	$268K	Buy	1,186 +59	+5%	+$15.1K	﹤0.01%	4092
2022 Q1	$312K	Buy	1,127 +516	+84%	+$143K	﹤0.01%	4165
2021 Q4	$134K	Hold	611	–	–	﹤0.01%	4629
2021 Q3	$277K	Buy	611 +115	+23%	+$57.4K	﹤0.01%	4305
2021 Q2	$291K	Buy	496 +185	+59%	+$97.8K	﹤0.01%	4179
2021 Q1	$194K	Buy	+311	New	+$200K	﹤0.01%	4118

Other funds holding VCNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management's VCNX Position: Q1 2024 in Review

Geode Capital Management sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 1,150 shares — an estimated $10.7K sold.

Geode Capital Management first reported a position in VCNX in Q1 2021 and held it in 12 quarters. The position peaked at $312K in Q1 2022. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

Geode Capital Management reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Geode Capital Management sold 1,150 Vaccinex, Inc. Common Stock shares in Q1 2024, an estimated $10.7K.
Geode Capital Management first reported a position in Vaccinex, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
Geode Capital Management's Vaccinex, Inc. Common Stock position peaked at $312K in Q1 2022.
12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.